Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cystatin 11 | 7.9E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||||
|
vexin | 0.13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||||
|
long intergenic non-protein coding RNA 592 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||||
|
DNA topoisomerase I pseudogene 2 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||||
|
crystallin zeta like 1 | 2.0E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.979 | 47 | 0 | 1990 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.100 | None | 0.960 | 446 | 6 | 1991 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 1.000 | 66 | 0 | 1992 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 0.981 | 160 | 1 | 1995 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.100 | None | 1.000 | 28 | 0 | 2005 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 20 | 0 | 2000 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.100 | None | 0.967 | 61 | 1 | 1994 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
phenotype | 0.100 | None | 0.933 | 15 | 0 | 1996 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.956 | 68 | 0 | 1990 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 59 | 1 | 2005 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.100 | None | 0.967 | 184 | 6 | 1992 | 2020 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 0.926 | 95 | 1 | 1995 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.982 | 109 | 0 | 1998 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.100 | None | 0.981 | 54 | 1 | 1998 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.100 | None | 1.000 | 47 | 0 | 2002 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 49 | 0 | 1997 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 0.984 | 63 | 0 | 2002 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.970 | 99 | 0 | 1999 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.050 | None | 0.800 | 5 | 0 | 2017 | 2019 |